• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Improved growth response of antibody/receptor chimera attained by the engineering of transmembrane domain.

作者信息

Kawahara Masahiro, Ogo Yuko, Ueda Hiroshi, Nagamune Teruyuki

机构信息

Department of Chemistry and Biotechnology, School of Engineering, University of Tokyo, Hongo, Bunkyo-ku, Tokyo 113-8656, Japan.

出版信息

Protein Eng Des Sel. 2004 Oct;17(10):715-9. doi: 10.1093/protein/gzh088. Epub 2004 Nov 17.

DOI:10.1093/protein/gzh088
PMID:15548567
Abstract

Structure-based design of antibody/cytokine receptor chimeras has permitted a growth signal transduction in response to non-natural ligands such as fluorescein-conjugated BSA as mimicry of cytokine-cytokine receptor systems. However, while tight on/off regulation is observed in the natural cytokine receptor systems, many chimeras constructed to date showed residual growth-promoting activity in the absence of ligands. Here we tried to reduce the basal growth signal intensity from a chimera by engineering the transmembrane domain (TM) that is thought to be involved in the interchain interaction of natural cytokine receptors. When the retroviral vectors encoding the chimeras with either the wild-type erythropoietin receptor (EpoR) TM or the one bearing two mutations in the leucine zipper motif were transduced to non-strictly interleukin-6-dependent 7TD1 cells, a tight antigen-dependent on/off regulation was attained, also demonstrating the first antigen-mediated genetically modified cell amplification of non-strictly factor-dependent cells. The results clearly indicate that the TM mutation is an effective means to improve the growth response of the antibody/receptor chimera.

摘要

相似文献

1
Improved growth response of antibody/receptor chimera attained by the engineering of transmembrane domain.
Protein Eng Des Sel. 2004 Oct;17(10):715-9. doi: 10.1093/protein/gzh088. Epub 2004 Nov 17.
2
Construction of a fluorescein-responsive chimeric receptor with strict ligand dependency.构建具有严格配体依赖性的荧光素响应嵌合受体。
Biotechnol Bioeng. 2008 Dec 1;101(5):975-84. doi: 10.1002/bit.21961.
3
Selection and growth regulation of genetically modified cells with hapten-specific antibody/receptor tyrosine kinase chimera.利用半抗原特异性抗体/受体酪氨酸激酶嵌合体对转基因细胞进行选择和生长调控。
Biotechnol Prog. 2009 Jul-Aug;25(4):1138-45. doi: 10.1002/btpr.185.
4
T cell growth control using hapten-specific antibody/interleukin-2 receptor chimera.使用半抗原特异性抗体/白细胞介素-2受体嵌合体进行T细胞生长控制。
Cytokine. 2009 Apr;46(1):127-36. doi: 10.1016/j.cyto.2008.12.020. Epub 2009 Feb 14.
5
Reversal of antigen-dependent signaling by two mutations in antibody/receptor chimera: implication of inverse agonism in cytokine receptor superfamily.抗体/受体嵌合体中的两个突变导致抗原依赖性信号转导的逆转:细胞因子受体超家族中反向激动作用的影响。
Biochem Pharmacol. 2004 Aug 1;68(3):539-48. doi: 10.1016/j.bcp.2004.04.014.
6
Mimicry of erythropoietin and interleukin-6 signalling by an antibody/cytokine receptor chimera in murine myeloid 32D cells.抗体/细胞因子受体嵌合体在小鼠骨髓32D细胞中对促红细胞生成素和白细胞介素-6信号的模拟
J Biochem. 2007 Apr;141(4):563-71. doi: 10.1093/jb/mvm056.
7
The upper cytokine-binding module and the Ig-like domain of the leukaemia inhibitory factor (LIF) receptor are sufficient for a functional LIF receptor complex.白血病抑制因子(LIF)受体的上部细胞因子结合模块和免疫球蛋白样结构域足以形成功能性LIF受体复合物。
J Mol Biol. 2002 Jan 25;315(4):637-46. doi: 10.1006/jmbi.2001.5282.
8
Selection of genetically modified cell population using hapten-specific antibody/receptor chimera.使用半抗原特异性抗体/受体嵌合体选择基因改造的细胞群体。
Biochem Biophys Res Commun. 2004 Feb 27;315(1):132-8. doi: 10.1016/j.bbrc.2004.01.030.
9
Growth promotion of genetically modified hematopoietic progenitors using an antibody/c-Mpl chimera.利用抗体/c-Mpl 嵌合体促进基因改造的造血祖细胞生长。
Cytokine. 2011 Sep;55(3):402-8. doi: 10.1016/j.cyto.2011.05.024. Epub 2011 Jun 22.
10
Selective expansion of genetically modified T cells using an antibody/interleukin-2 receptor chimera.使用抗体/白细胞介素-2受体嵌合体对基因改造的T细胞进行选择性扩增。
J Immunol Methods. 2008 Aug 20;337(1):16-23. doi: 10.1016/j.jim.2008.05.003. Epub 2008 Jun 10.

引用本文的文献

1
Refining minimal engineered receptors for specific activation of on-target signaling molecules.优化用于特异性激活靶信号分子的最小化工程受体。
Sci Rep. 2024 Dec 30;14(1):31671. doi: 10.1038/s41598-024-81259-4.
2
Construction of antibody/insulin receptor chimera for growth induction of mammalian cells.构建抗体/胰岛素受体嵌合体以诱导哺乳动物细胞生长。
Cytotechnology. 2013 Dec;65(6):945-53. doi: 10.1007/s10616-013-9571-5. Epub 2013 Apr 25.
3
Growth control of hybridoma cells with an artificially induced EpoR-gp130 heterodimer.
用人工诱导的 EpoR-gp130 异二聚体控制杂交瘤细胞的生长。
Cytotechnology. 2006 Nov;52(3):171-9. doi: 10.1007/s10616-006-9035-2. Epub 2006 Dec 5.